Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?

Background To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Methods Data from 3,993 individuals (2,027 women) a...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC endocrine disorders Ročník 13; číslo 1; s. 12
Hlavní autori:	Balbach, Lisa, Wallaschofski, Henri, Völzke, Henry, Nauck, Matthias, Dörr, Marcus, Haring, Robin
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 21.03.2013 BioMed Central Ltd Springer Nature B.V
Predmet:	Diabetes Diabetes mellitus Endocrinology Gender Insulin resistance Medicine Medicine & Public Health Metabolic Diseases Metabolic disorders Metabolic syndrome Metabolic syndrome X Physiological aspects Prolactin Research Article Risk factors rology Ships Studies Type 2 diabetes Germany Poland, Pomerania Multivariable Regression Model Cardiometabolic Risk Factor Serum Prolactin Concentration Incident MetS
ISSN:	1472-6823, 1472-6823
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Background To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Methods Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Results Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 – 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 – 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 – 0.95 in men, and 0.84; 95% CI, 0.71 – 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. Conclusion The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM.
AbstractList	To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort.BACKGROUNDTo investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort.Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman.METHODSData from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman.Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM.RESULTSCross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM.The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM.CONCLUSIONThe present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM. To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM. To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM. Background: To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Methods: Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Results: Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. Conclusion: The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM. Background To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Methods Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Results Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 – 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 – 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 – 0.95 in men, and 0.84; 95% CI, 0.71 – 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. Conclusion The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM. Doc number: 12 Abstract Background: To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously observed in small and selected study samples, in a large population-based cohort. Methods: Data from 3,993 individuals (2,027 women) aged 20-79 years from the population-based Study of Health of Pomerania (SHIP) were used to analyse cross-sectional and longitudinal associations of PRL with MetS and T2DM risk in age- and multivariable-adjusted Poisson regression models. PRL were log-transformed and modelled as continuous (per standard deviation (SD) increase) and categorical predictor (sex-specific quartiles) variable, separately for men and woman. Results: Cross-sectional analyses showed an inverse association between low PRL concentrations and prevalent T2DM risk in men and women after multivariable-adjustment (men: Q1 vs. Q4: relative risk (RR), 1.55; 95% confidence interval (CI), 1.13 - 2.14; women: Q1 vs. Q4: RR, 1.70; 95% CI, 1.10 - 2.62). Likewise, higher PRL concentrations were associated with significantly lower T2DM risk (RR per SD increase in log-PRL: 0.83; 95% CI, 0.72 - 0.95 in men, and 0.84; 95% CI, 0.71 - 0.98 in women, respectively). An inverse association between PRL and MetS risk was not retained after multivariable adjustment. Longitudinal analyses yielded no association of PRL with incident MetS or T2DM. Conclusion: The present study is the first large population-based study reporting a cross-sectional inverse association between PRL and prevalent T2DM in both genders. But the absent longitudinal associations do not support a causal role of PRL as a risk factor of incident MetS or T2DM.
ArticleNumber	12
Audience	Academic
Author	Haring, Robin Völzke, Henry Nauck, Matthias Wallaschofski, Henri Balbach, Lisa Dörr, Marcus
AuthorAffiliation	1 Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, Greifswald, 17475, Germany 4 Department of Cardiology, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, Greifswald, 17475, Germany 3 Institute for Community Medicine, University Medicine Greifswald, Walther-Rathenau-Straße 48, Greifswald, 17475, Germany 2 DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany
AuthorAffiliation_xml	– name: 4 Department of Cardiology, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, Greifswald, 17475, Germany – name: 2 DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany – name: 3 Institute for Community Medicine, University Medicine Greifswald, Walther-Rathenau-Straße 48, Greifswald, 17475, Germany – name: 1 Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, Greifswald, 17475, Germany
Author_xml	– sequence: 1 givenname: Lisa surname: Balbach fullname: Balbach, Lisa organization: Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald – sequence: 2 givenname: Henri surname: Wallaschofski fullname: Wallaschofski, Henri organization: Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, DZHK (German Centre for Cardiovascular Research), partner site Greifswald – sequence: 3 givenname: Henry surname: Völzke fullname: Völzke, Henry organization: DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Institute for Community Medicine, University Medicine Greifswald – sequence: 4 givenname: Matthias surname: Nauck fullname: Nauck, Matthias organization: Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, DZHK (German Centre for Cardiovascular Research), partner site Greifswald – sequence: 5 givenname: Marcus surname: Dörr fullname: Dörr, Marcus organization: DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Department of Cardiology, University Medicine Greifswald – sequence: 6 givenname: Robin surname: Haring fullname: Haring, Robin email: robin.haring@uni-greifswald.de organization: Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, DZHK (German Centre for Cardiovascular Research), partner site Greifswald
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/23517652$$D View this record in MEDLINE/PubMed
BookMark	eNqNks1r3DAQxUVJyVdz7q0IeunFifVhSXtpCaFNCoEeEuhRyPJoq9SWtpId2P--cjZJN6GBIIOM5vcew5s5QDshBkDoPamPCVHihHBJK6Eoq0j56Bu0__iys_W_hw5yvqlrIhWtd9EeZQ2RoqH76OcVpGnAqxR7Y0cfsI3BQhiTGX0MGZuMk8-_sSvVmHB0eIDRtLH3Fud16FIcAJfCuF4BprjzpoUR8pd36K0zfYaj-_sQXX_7en12UV3-OP9-dnpZWUHVWDFDamWg40wuFoQ1nXREtJ0yXApGHYGWt1Y4K4ELbpW0tnEdNW3hu9pSdog-b2xXUztAt-m816vkB5PWOhqvn1aC_6WX8VYzQbiSvBh8ujdI8c8EedSDzxb63gSIU9aEccVVIwh9BUo5U1IyVdCPz9CbOKVQgpgpyiRpqPxHLU0P2gcXS4t2NtWnDeOCFWhRqOP_UOV0MPgyLXC-vD8RfNjO5DGMh6EXoNkANsWcEzht_Xg37-Lse01qPS-XntdHz-tTmtZ3AZw80z1Yv6yoN4pcyLCEtJXDC5K_0gXdpQ
CitedBy_id	crossref_primary_10_1007_s12020_019_02170_x crossref_primary_10_3389_fendo_2022_964808 crossref_primary_10_4093_dmj_2017_41_3_195 crossref_primary_10_3389_fendo_2022_1001703 crossref_primary_10_3389_fendo_2021_571229 crossref_primary_10_1016_j_mehy_2021_110662 crossref_primary_10_14341_omet12475 crossref_primary_10_3389_fendo_2023_1219119 crossref_primary_10_3389_fendo_2022_1002320 crossref_primary_10_1001_jamainternmed_2018_1806 crossref_primary_10_1093_humrep_deu133 crossref_primary_10_3389_fendo_2022_1017468 crossref_primary_10_1186_s12876_022_02619_w crossref_primary_10_1038_tp_2016_50 crossref_primary_10_3389_fendo_2021_619696 crossref_primary_10_1007_s11154_024_09900_1 crossref_primary_10_1007_s12020_015_0655_1 crossref_primary_10_3389_fendo_2022_1069625 crossref_primary_10_1038_s41598_024_65239_2 crossref_primary_10_3390_ijerph16061086 crossref_primary_10_1016_j_ygcen_2013_12_014 crossref_primary_10_1016_j_bbadis_2018_03_024 crossref_primary_10_1111_jne_12888 crossref_primary_10_1159_000521013 crossref_primary_10_4093_dmj_2017_41_3_168 crossref_primary_10_1007_s11154_024_09916_7 crossref_primary_10_1016_j_rpsm_2015_11_003 crossref_primary_10_1371_journal_pone_0175204 crossref_primary_10_1007_s00125_018_4733_9 crossref_primary_10_1007_s12020_024_03743_1 crossref_primary_10_1007_s40618_023_02101_8 crossref_primary_10_4103_jcor_jcor_78_25 crossref_primary_10_1080_17446651_2022_2144829 crossref_primary_10_1007_s11154_023_09847_9 crossref_primary_10_1016_j_tem_2020_01_004 crossref_primary_10_1186_1471_2164_15_197 crossref_primary_10_1007_s11102_025_01544_x crossref_primary_10_1016_j_dsx_2018_07_007 crossref_primary_10_1007_s11154_024_09912_x crossref_primary_10_1016_j_pnpbp_2021_110332 crossref_primary_10_1007_s40619_024_01530_8 crossref_primary_10_3389_fendo_2022_1018090 crossref_primary_10_1055_a_2209_0538 crossref_primary_10_1186_s42358_024_00394_8 crossref_primary_10_1186_s12902_022_01225_x crossref_primary_10_1080_17446651_2018_1434412 crossref_primary_10_1007_s11154_024_09895_9 crossref_primary_10_1093_eurjpc_zwad176 crossref_primary_10_1186_s13006_019_0238_5 crossref_primary_10_1093_ijnp_pyaa097 crossref_primary_10_1210_clinem_dgac346 crossref_primary_10_1016_j_cca_2023_117688 crossref_primary_10_2337_dc16_0043 crossref_primary_10_3389_fendo_2019_00327 crossref_primary_10_1371_journal_pone_0301496 crossref_primary_10_3389_fendo_2022_1015520 crossref_primary_10_1111_jcmm_70067 crossref_primary_10_3389_fendo_2020_00263 crossref_primary_10_3389_fphys_2014_00231 crossref_primary_10_1002_ajmg_b_32712 crossref_primary_10_1159_000357810 crossref_primary_10_1007_s11154_024_09886_w crossref_primary_10_1007_s11102_024_01393_0 crossref_primary_10_1016_j_rpsmen_2016_06_001 crossref_primary_10_1007_s12020_025_04310_y crossref_primary_10_1055_a_1258_8625 crossref_primary_10_52667_2712_9179_2025_5_1_16_26 crossref_primary_10_1016_j_diabres_2020_108247 crossref_primary_10_3389_fphar_2021_718800 crossref_primary_10_1016_j_metabol_2016_10_005
Cites_doi	10.1111/j.1365-2605.2010.01076.x 10.1046/j.1463-1326.2003.00250.x 10.1210/endo.143.4.8722 10.1055/s-0030-1261876 10.1146/annurev.publhealth.28.082206.094100 10.1210/jc.2003-031295 10.1530/EJE-10-1074 10.1038/oby.2008.297 10.1111/j.1463-1326.2006.00671.x 10.1097/TP.0b013e3181d98af1 10.1016/j.transproceed.2008.01.009 10.1210/jc.2011-2134 10.1002/jcp.24023 10.1007/s11102-010-0277-9 10.1016/j.autrev.2009.02.031 10.2337/db09-0031 10.1111/j.1365-2265.2011.04075.x 10.1210/jc.83.3.761 10.1093/ije/dyp394 10.1016/0006-3223(94)91147-9 10.1176/appi.ajp.160.2.284 10.1007/s11695-009-9856-0 10.1677/JOE-07-0043 10.1210/jc.2008-0222 10.1016/j.atherosclerosis.2012.01.017 10.2105/AJPH.2004.059204 10.1016/S0024-3205(02)01775-7 10.1055/s-0030-1247406 10.1530/EJE-10-0246 10.1007/s00125-011-2102-z 10.1161/CIRCULATIONAHA.109.192644 10.3810/pgm.2012.01.2514 10.1210/jc.2005-1654 10.1007/s00592-009-0112-9 10.3109/13685538.2010.529194 10.1210/en.2004-0201 10.1007/s11102-008-0106-6 10.1038/oby.2010.150 10.1210/er.2009-0046 10.1016/j.jclinepi.2008.06.010 10.1111/j.1743-6109.2008.01206.x 10.1111/j.1365-2265.2006.02469.x 10.1093/clinchem/41.12.1761 10.1097/HJR.0b013e32833c1a8d
ContentType	Journal Article
Copyright	Balbach et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. COPYRIGHT 2013 BioMed Central Ltd. 2013 Balbach et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © 2013 Balbach et al.; licensee BioMed Central Ltd. 2013 Balbach et al.; licensee BioMed Central Ltd.
Copyright_xml	– notice: Balbach et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: COPYRIGHT 2013 BioMed Central Ltd. – notice: 2013 Balbach et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright © 2013 Balbach et al.; licensee BioMed Central Ltd. 2013 Balbach et al.; licensee BioMed Central Ltd.
DBID	C6C AAYXX CITATION NPM 3V. 7QP 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7U1 C1K 5PM
DOI	10.1186/1472-6823-13-12
DatabaseName	Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Database Suite (ProQuest) ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management
DatabaseTitleList	MEDLINE - Academic PubMed Risk Abstracts Publicly Available Content Database
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1472-6823
EndPage	12
ExternalDocumentID	PMC3614874 2933206421 A534635279 23517652 10_1186_1472_6823_13_12
Genre	Journal Article
GeographicLocations	Germany Poland, Pomerania
GeographicLocations_xml	– name: Germany – name: Poland, Pomerania
GroupedDBID	--- 0R~ 23N 2WC 4.4 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M AAYXX AFFHD CITATION ALIPV NPM 3V. 7QP 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 7U1 C1K 5PM
ID	FETCH-LOGICAL-c628t-3a108aed43799135d7f16bd8a47632f1eb4bc6fc7e464c87cc5fd2ab437d0c23
IEDL.DBID	7X7
ISICitedReferencesCount	77
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000317358100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1472-6823
IngestDate	Tue Nov 04 01:36:42 EST 2025 Mon Oct 06 18:21:22 EDT 2025 Thu Sep 04 18:20:36 EDT 2025 Mon Oct 06 18:34:53 EDT 2025 Tue Nov 11 10:57:43 EST 2025 Tue Nov 04 18:21:14 EST 2025 Mon Jul 21 05:25:36 EDT 2025 Tue Nov 18 21:15:07 EST 2025 Sat Nov 29 03:15:06 EST 2025 Sat Sep 06 07:29:45 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Multivariable Regression Model Cardiometabolic Risk Factor Serum Prolactin Concentration Incident MetS
Language	English
License	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c628t-3a108aed43799135d7f16bd8a47632f1eb4bc6fc7e464c87cc5fd2ab437d0c23
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1
OpenAccessLink	https://www.proquest.com/docview/1322371527?pq-origsite=%requestingapplication%
PMID	23517652
PQID	1322371527
PQPubID	44656
PageCount	1
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_3614874 proquest_miscellaneous_1348485612 proquest_miscellaneous_1324387738 proquest_journals_1322371527 gale_infotracmisc_A534635279 gale_infotracacademiconefile_A534635279 pubmed_primary_23517652 crossref_citationtrail_10_1186_1472_6823_13_12 crossref_primary_10_1186_1472_6823_13_12 springer_journals_10_1186_1472_6823_13_12
PublicationCentury	2000
PublicationDate	2013-03-21
PublicationDateYYYYMMDD	2013-03-21
PublicationDate_xml	– month: 03 year: 2013 text: 2013-03-21 day: 21
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	BMC endocrine disorders
PublicationTitleAbbrev	BMC Endocr Disord
PublicationTitleAlternate	BMC Endocr Disord
PublicationYear	2013
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V
References	Corona, Rastrelli, Boddi, Monami, Melani, Balzi, Sforza, Forti, Mannucci, Maggi (CR11) 2011; 34 Mingrone, Manco, Iaconelli, Gniuli, Bracaglia, Leccesi, Calvani, Nolfe, Basu, Berria (CR9) 2008; 16 Afifi, Kotlerman, Ettner, Cowan (CR25) 2007; 28 Haring, Friedrich, Volzke, Vasan, Felix, Dorr, Meyer Zu Schwabedissen, Nauck, Wallaschofski (CR40) 2012 Haring, Alte, Volzke, Sauer, Wallaschofski, John, Schmidt (CR13) 2009; 62 Resmini, Minuto, Colao, Ferone (CR45) 2009; 46 Serri, Li, Mamputu, Beauchamp, Maingrette, Renier (CR8) 2006; 64 Terra, Garay-Malpartida, Wailemann, Sogayar, Labriola (CR38) 2011; 54 Muldoon, Mackey, Korytkowski, Flory, Pollock, Manuck (CR27) 2006; 91 Haring, Volzke, Felix, Schipf, Dorr, Rosskopf, Nauck, Schofl, Wallaschofski (CR21) 2009; 58 Katznelson, Riskind, Saxe, Klibanski (CR42) 1998; 83 Ryan, Collins, Thakore (CR30) 2003; 160 Freemark, Avril, Fleenor, Driscoll, Petro, Opara, Kendall, Oden, Bridges, Binart (CR7) 2002; 143 Ben-Jonathan, Hugo, Brandebourg, LaPensee (CR3) 2006; 17 Ernst, Thurnheer, Schultes (CR10) 2009; 19 Molitch (CR24) 2008; 11 Rothman, Greenland (CR46) 2005; 95 Haring, Wallaschofski, Nauck, Felix, Schmidt, Dorr, Sauer, Wilmking, Volzke (CR22) 2010; 118 Prasad, Ryan, Celzo, Stapleton (CR4) 2012; 124 Brandebourg, Hugo, Ben-Jonathan (CR2) 2007; 9 Friedrich, Schneider, Spielhagen, Markus, Haring, Grabe, Buchfelder, Wallaschofski, Nauck (CR39) 2011; 75 Haring, Hannemann, John, Radke, Nauck, Wallaschofski, Owen, Adaway, Keevil, Brabant (CR15) 2012; 97 Nauck, Winkler, Marz, Wieland (CR16) 1995; 41 Lidfeldt, Nyberg, Nerbrand, Samsioe, Schersten, Agardh (CR23) 2003; 5 Brelje, Stout, Bhagroo, Sorenson (CR6) 2004; 145 Völzke, Alte, Schmidt, Radke, Lorbeer, Friedrich, Aumann, Lau, Piontek, Born (CR12) 2011; 40 Schipf, Alte, Voelzke, Friedrich, Haring, Lohmann, Nauck, Felix, Hoffmann, John (CR20) 2010; 5 Maratou, Hadjidakis, Peppa, Alevizaki, Tsegka, Lambadiari, Mitrou, Boutati, Kollias, Economopoulos (CR43) 2010; 163 Yamamoto, Mita, Ricordi, Messinger, Miki, Sakuma, Timoneri, Barker, Fornoni, Molano (CR37) 2010; 89 Meaney, O'Keane (CR28) 2002; 71 Muldoon, Mackey, Williams, Korytkowski, Flory, Manuck (CR32) 2004; 89 Weinhaus, Stout, Bhagroo, Brelje, Sorenson (CR35) 2007; 193 Haring, Baumeister, Völzke, Dorr, Felix, Kroemer, Nauck, Wallaschofski (CR17) 2011; 18 Corona, Mannucci, Jannini, Lotti, Ricca, Monami, Boddi, Bandini, Balercia, Forti (CR26) 2009; 6 Rao, Gross, Strebel, Halaris, Huber, Braunig, Marler (CR29) 1994; 35 Alberti, Eckel, Grundy, Zimmet, Cleeman, Donato, Fruchart, James, Loria, Smith (CR18) 2009; 120 Mitrou, Raptis, Dimitriadis (CR44) 2010; 31 Torkler, Wallaschofski, Baumeister, Volzke, Dorr, Felix, Rettig, Nauck, Haring (CR14) 2011; 14 Berinder, Nystrom, Hoybye, Hall, Hulting (CR33) 2011; 14 Haring, Volzke, Vasan, Felix, Nauck, Dorr, Wallaschofski (CR41) 2012; 221 Yamamoto, Ricordi, Mita, Miki, Sakuma, Molano, Fornoni, Pileggi, Inverardi, Ichii (CR36) 2008; 40 Oberweis, Gragnoli (CR31) 2012; 227 dos Santos Silva, Barbosa, Lima, Warszawski, Fontes, Domingues, Gadelha (CR34) 2011; 19 Hannemann, Meisinger, Bidlingmaier, Doring, Thorand, Heier, Belcredi, Ladwig, Wallaschofski, Friedrich (CR19) 2011; 164 Cejkova, Fojtikova, Cerna (CR1) 2009; 9 Rosenzweig, Ferrannini, Grundy, Haffner, Heine, Horton, Kawamori (CR5) 2008; 93 P Mitrou (165_CR44) 2010; 31 JL Rosenzweig (165_CR5) 2008; 93 R Haring (165_CR13) 2009; 62 R Haring (165_CR22) 2010; 118 P Cejkova (165_CR1) 2009; 9 J Lidfeldt (165_CR23) 2003; 5 AA Afifi (165_CR25) 2007; 28 KJ Rothman (165_CR46) 2005; 95 TC Brelje (165_CR6) 2004; 145 N Ben-Jonathan (165_CR3) 2006; 17 LF Terra (165_CR38) 2011; 54 R Haring (165_CR17) 2011; 18 H Prasad (165_CR4) 2012; 124 E Maratou (165_CR43) 2010; 163 E Resmini (165_CR45) 2009; 46 AJ Weinhaus (165_CR35) 2007; 193 MF Muldoon (165_CR32) 2004; 89 K Berinder (165_CR33) 2011; 14 M Nauck (165_CR16) 1995; 41 ME Molitch (165_CR24) 2008; 11 R Haring (165_CR21) 2009; 58 B Ernst (165_CR10) 2009; 19 ML Rao (165_CR29) 1994; 35 G Corona (165_CR11) 2011; 34 G Mingrone (165_CR9) 2008; 16 T Yamamoto (165_CR37) 2010; 89 B Oberweis (165_CR31) 2012; 227 N Friedrich (165_CR39) 2011; 75 M Freemark (165_CR7) 2002; 143 CM dos Santos Silva (165_CR34) 2011; 19 R Haring (165_CR15) 2012; 97 T Yamamoto (165_CR36) 2008; 40 T Brandebourg (165_CR2) 2007; 9 H Völzke (165_CR12) 2011; 40 G Corona (165_CR26) 2009; 6 AM Meaney (165_CR28) 2002; 71 MF Muldoon (165_CR27) 2006; 91 R Haring (165_CR40) 2012 O Serri (165_CR8) 2006; 64 KG Alberti (165_CR18) 2009; 120 A Hannemann (165_CR19) 2011; 164 L Katznelson (165_CR42) 1998; 83 R Haring (165_CR41) 2012; 221 S Torkler (165_CR14) 2011; 14 S Schipf (165_CR20) 2010; 5 MC Ryan (165_CR30) 2003; 160 22293228 - Atherosclerosis. 2012 Apr;221(2):570-6 21521343 - Clin Endocrinol (Oxf). 2011 Oct;75(4):561-6 15142985 - Endocrinology. 2004 Sep;145(9):4162-75 19805654 - Circulation. 2009 Oct 20;120(16):1640-5 16517173 - Trends Endocrinol Metab. 2006 Apr;17(3):110-6 17587388 - Diabetes Obes Metab. 2007 Jul;9(4):464-76 21357289 - Eur J Endocrinol. 2011 May;164(5):751-8 16303834 - J Clin Endocrinol Metab. 2006 Feb;91(2):718-21 20519325 - Endocr Rev. 2010 Oct;31(5):663-79 14715860 - J Clin Endocrinol Metab. 2004 Jan;89(1):266-71 22314111 - Postgrad Med. 2012 Jan;124(1):21-30 19581420 - Diabetes. 2009 Sep;58(9):2027-31 17535875 - J Endocrinol. 2007 Jun;193(3):367-81 7909693 - Biol Psychiatry. 1994 Feb 1;35(3):151-63 18834716 - J Clin Epidemiol. 2009 Mar;62(3):252-60 18374075 - Transplant Proc. 2008 Mar;40(2):382-3 16030331 - Am J Public Health. 2005;95 Suppl 1:S144-50 17112339 - Annu Rev Public Health. 2007;28:95-111 19322513 - Acta Diabetol. 2009 Jun;46(2):85-95 21394492 - Diabetologia. 2011 Jun;54(6):1388-97 12088758 - Life Sci. 2002 Jul 19;71(9):979-92 9506722 - J Clin Endocrinol Metab. 1998 Mar;83(3):761-4 22105468 - J Cell Physiol. 2012 Aug;227(8):3001-6 18535540 - Obesity (Silver Spring). 2008 Aug;16(8):1831-7 20522124 - Int J Androl. 2011 Jun;34(3):217-24 19248843 - Autoimmun Rev. 2009 Sep;9(1):23-7 11897695 - Endocrinology. 2002 Apr;143(4):1378-85 20559294 - Obesity (Silver Spring). 2011 Apr;19(4):800-5 21087174 - Aging Male. 2011 Sep;14(3):176-82 18664543 - J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89 22162468 - J Clin Endocrinol Metab. 2012 Feb;97(2):408-15 7497617 - Clin Chem. 1995 Dec;41(12 Pt 1):1761-7 20357700 - Transplantation. 2010 Jun 15;89(11):1328-35 21128120 - Pituitary. 2011 Sep;14(3):199-207 20562628 - Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):86-96 19210705 - J Sex Med. 2009 May;6(5):1457-66 12562574 - Am J Psychiatry. 2003 Feb;160(2):284-9 18404390 - Pituitary. 2008;11(2):209-18 19430852 - Obes Surg. 2009 Aug;19(8):1159-62 12630935 - Diabetes Obes Metab. 2003 Mar;5(2):106-12 20625974 - Exp Clin Endocrinol Diabetes. 2010 Nov;118(10):685-91 22843444 - Eur Heart J. 2014 May;35(18):1215-21 20167617 - Int J Epidemiol. 2011 Apr;40(2):294-307 16584506 - Clin Endocrinol (Oxf). 2006 Apr;64(4):366-70 20643758 - Eur J Endocrinol. 2010 Oct;163(4):625-30
References_xml	– volume: 34 start-page: 217 issue: 3 year: 2011 end-page: 224 ident: CR11 article-title: Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction publication-title: Int J Androl doi: 10.1111/j.1365-2605.2010.01076.x – volume: 5 start-page: 106 issue: 2 year: 2003 end-page: 112 ident: CR23 article-title: Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study publication-title: Diabetes Obes Metab doi: 10.1046/j.1463-1326.2003.00250.x – volume: 143 start-page: 1378 issue: 4 year: 2002 end-page: 1385 ident: CR7 article-title: Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance publication-title: Endocrinology doi: 10.1210/endo.143.4.8722 – volume: 118 start-page: 685 issue: 10 year: 2010 end-page: 691 ident: CR22 article-title: Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-0030-1261876 – volume: 28 start-page: 95 year: 2007 end-page: 111 ident: CR25 article-title: Methods for improving regression analysis for skewed continuous or counted responses publication-title: Annu Rev Public Health doi: 10.1146/annurev.publhealth.28.082206.094100 – volume: 89 start-page: 266 issue: 1 year: 2004 end-page: 271 ident: CR32 article-title: Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2003-031295 – volume: 164 start-page: 751 issue: 5 year: 2011 end-page: 758 ident: CR19 article-title: Association of plasma aldosterone with the metabolic syndrome in two German populations publication-title: Eur J Endocrinol doi: 10.1530/EJE-10-1074 – volume: 16 start-page: 1831 issue: 8 year: 2008 end-page: 1837 ident: CR9 article-title: Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2008.297 – volume: 9 start-page: 464 issue: 4 year: 2007 end-page: 476 ident: CR2 article-title: Adipocyte prolactin: regulation of release and putative functions publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2006.00671.x – volume: 89 start-page: 1328 issue: 11 year: 2010 end-page: 1335 ident: CR37 article-title: Prolactin supplementation to culture medium improves beta-cell survival publication-title: Transplantation doi: 10.1097/TP.0b013e3181d98af1 – volume: 40 start-page: 382 issue: 2 year: 2008 end-page: 383 ident: CR36 article-title: beta-Cell specific cytoprotection by prolactin on human islets publication-title: Transplant Proc doi: 10.1016/j.transproceed.2008.01.009 – volume: 97 start-page: 408 issue: 2 year: 2012 end-page: 415 ident: CR15 article-title: Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2011-2134 – volume: 227 start-page: 3001 issue: 8 year: 2012 end-page: 3006 ident: CR31 article-title: Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes publication-title: J Cell Physiol doi: 10.1002/jcp.24023 – volume: 14 start-page: 199 issue: 3 year: 2011 end-page: 207 ident: CR33 article-title: Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy publication-title: Pituitary doi: 10.1007/s11102-010-0277-9 – volume: 9 start-page: 23 issue: 1 year: 2009 end-page: 27 ident: CR1 article-title: Immunomodulatory role of prolactin in diabetes development publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2009.02.031 – volume: 58 start-page: 2027 issue: 9 year: 2009 end-page: 2031 ident: CR21 article-title: Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania publication-title: Diabetes doi: 10.2337/db09-0031 – volume: 75 start-page: 561 issue: 4 year: 2011 end-page: 566 ident: CR39 article-title: The association of serum prolactin concentration with inflammatory biomarkers - cross-sectional findings from the population-based Study of Health in Pomerania publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2011.04075.x – volume: 83 start-page: 761 issue: 3 year: 1998 end-page: 764 ident: CR42 article-title: Prolactin pulsatile characteristics in postmenopausal women publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.83.3.761 – volume: 40 start-page: 294 issue: 2 year: 2011 end-page: 307 ident: CR12 article-title: Cohort profile: the study of health in pomerania publication-title: Int J Epidemiol doi: 10.1093/ije/dyp394 – volume: 18 start-page: 86 issue: 1 year: 2011 end-page: 96 ident: CR17 article-title: Prospective Association of Low Total Testosterone Concentrations with an Adverse Lipid Profile and Increased Incident Dyslipidemia publication-title: Eur J Cardiovasc Prev Rehabil – volume: 35 start-page: 151 issue: 3 year: 1994 end-page: 163 ident: CR29 article-title: Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia publication-title: Biol Psychiatry doi: 10.1016/0006-3223(94)91147-9 – volume: 160 start-page: 284 issue: 2 year: 2003 end-page: 289 ident: CR30 article-title: Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.2.284 – volume: 19 start-page: 1159 issue: 8 year: 2009 end-page: 1162 ident: CR10 article-title: Basal serum prolactin levels in obesity–unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss publication-title: Obes Surg doi: 10.1007/s11695-009-9856-0 – volume: 41 start-page: 1761 issue: 12 Pt 1 year: 1995 end-page: 1767 ident: CR16 article-title: Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining publication-title: Clin Chem – volume: 193 start-page: 367 issue: 3 year: 2007 end-page: 381 ident: CR35 article-title: Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy publication-title: J Endocrinol doi: 10.1677/JOE-07-0043 – volume: 93 start-page: 3671 issue: 10 year: 2008 end-page: 3689 ident: CR5 article-title: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2008-0222 – volume: 64 start-page: 366 issue: 4 year: 2006 end-page: 370 ident: CR8 article-title: The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy publication-title: Clin Endocrinol (Oxf) – volume: 221 start-page: 570 issue: 2 year: 2012 end-page: 576 ident: CR41 article-title: Sex-specific associations of serum prolactin concentrations with cardiac remodeling: longitudinal results from the Study of Health Pomerania (SHIP) publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.01.017 – volume: 95 start-page: S144 issue: Suppl 1 year: 2005 end-page: 150 ident: CR46 article-title: Causation and causal inference in epidemiology publication-title: Am J Public Health doi: 10.2105/AJPH.2004.059204 – volume: 71 start-page: 979 issue: 9 year: 2002 end-page: 992 ident: CR28 article-title: Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia publication-title: Life Sci doi: 10.1016/S0024-3205(02)01775-7 – year: 2012 ident: CR40 article-title: Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality publication-title: Eur Heart J – volume: 5 start-page: 161 year: 2010 end-page: 168 ident: CR20 article-title: Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP) publication-title: Diabetologie Stoffwechsel doi: 10.1055/s-0030-1247406 – volume: 163 start-page: 625 issue: 4 year: 2010 end-page: 630 ident: CR43 article-title: Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism publication-title: Eur J Endocrinol doi: 10.1530/EJE-10-0246 – volume: 54 start-page: 1388 issue: 6 year: 2011 end-page: 1397 ident: CR38 article-title: Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways publication-title: Diabetologia doi: 10.1007/s00125-011-2102-z – volume: 120 start-page: 1640 issue: 16 year: 2009 end-page: 1645 ident: CR18 article-title: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 124 start-page: 21 issue: 1 year: 2012 end-page: 30 ident: CR4 article-title: Metabolic syndrome: definition and therapeutic implications publication-title: Postgrad Med doi: 10.3810/pgm.2012.01.2514 – volume: 91 start-page: 718 issue: 2 year: 2006 end-page: 721 ident: CR27 article-title: The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2005-1654 – volume: 46 start-page: 85 issue: 2 year: 2009 end-page: 95 ident: CR45 article-title: Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities publication-title: Acta Diabetol doi: 10.1007/s00592-009-0112-9 – volume: 14 start-page: 176 issue: 3 year: 2011 end-page: 182 ident: CR14 article-title: Inverse association between total testosterone concentrations, incident hypertension and blood pressure publication-title: Aging Male doi: 10.3109/13685538.2010.529194 – volume: 145 start-page: 4162 issue: 9 year: 2004 end-page: 4175 ident: CR6 article-title: Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans publication-title: Endocrinology doi: 10.1210/en.2004-0201 – volume: 11 start-page: 209 issue: 2 year: 2008 end-page: 218 ident: CR24 article-title: Drugs and prolactin publication-title: Pituitary doi: 10.1007/s11102-008-0106-6 – volume: 17 start-page: 110 issue: 3 year: 2006 end-page: 116 ident: CR3 article-title: Focus on prolactin as a metabolic hormone. Trends in endocrinology and metabolism publication-title: TEM – volume: 19 start-page: 800 issue: 4 year: 2011 end-page: 805 ident: CR34 article-title: BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2010.150 – volume: 31 start-page: 663 issue: 5 year: 2010 end-page: 679 ident: CR44 article-title: Insulin action in hyperthyroidism: a focus on muscle and adipose tissue publication-title: Endocr Rev doi: 10.1210/er.2009-0046 – volume: 62 start-page: 252 issue: 3 year: 2009 end-page: 260 ident: CR13 article-title: Extended recruitment efforts minimize attrition but not necessarily bias publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2008.06.010 – volume: 6 start-page: 1457 issue: 5 year: 2009 end-page: 1466 ident: CR26 article-title: Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction publication-title: J Sex Med doi: 10.1111/j.1743-6109.2008.01206.x – volume: 95 start-page: S144 issue: Suppl 1 year: 2005 ident: 165_CR46 publication-title: Am J Public Health doi: 10.2105/AJPH.2004.059204 – volume: 160 start-page: 284 issue: 2 year: 2003 ident: 165_CR30 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.2.284 – volume: 64 start-page: 366 issue: 4 year: 2006 ident: 165_CR8 publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2006.02469.x – volume: 9 start-page: 23 issue: 1 year: 2009 ident: 165_CR1 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2009.02.031 – volume: 221 start-page: 570 issue: 2 year: 2012 ident: 165_CR41 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.01.017 – volume: 40 start-page: 294 issue: 2 year: 2011 ident: 165_CR12 publication-title: Int J Epidemiol doi: 10.1093/ije/dyp394 – volume: 41 start-page: 1761 issue: 12 Pt 1 year: 1995 ident: 165_CR16 publication-title: Clin Chem doi: 10.1093/clinchem/41.12.1761 – volume: 120 start-page: 1640 issue: 16 year: 2009 ident: 165_CR18 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 227 start-page: 3001 issue: 8 year: 2012 ident: 165_CR31 publication-title: J Cell Physiol doi: 10.1002/jcp.24023 – volume: 145 start-page: 4162 issue: 9 year: 2004 ident: 165_CR6 publication-title: Endocrinology doi: 10.1210/en.2004-0201 – volume: 5 start-page: 106 issue: 2 year: 2003 ident: 165_CR23 publication-title: Diabetes Obes Metab doi: 10.1046/j.1463-1326.2003.00250.x – volume: 28 start-page: 95 year: 2007 ident: 165_CR25 publication-title: Annu Rev Public Health doi: 10.1146/annurev.publhealth.28.082206.094100 – volume: 71 start-page: 979 issue: 9 year: 2002 ident: 165_CR28 publication-title: Life Sci doi: 10.1016/S0024-3205(02)01775-7 – volume: 16 start-page: 1831 issue: 8 year: 2008 ident: 165_CR9 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2008.297 – volume: 118 start-page: 685 issue: 10 year: 2010 ident: 165_CR22 publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-0030-1261876 – volume: 75 start-page: 561 issue: 4 year: 2011 ident: 165_CR39 publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2011.04075.x – volume: 6 start-page: 1457 issue: 5 year: 2009 ident: 165_CR26 publication-title: J Sex Med doi: 10.1111/j.1743-6109.2008.01206.x – volume: 91 start-page: 718 issue: 2 year: 2006 ident: 165_CR27 publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2005-1654 – volume: 14 start-page: 199 issue: 3 year: 2011 ident: 165_CR33 publication-title: Pituitary doi: 10.1007/s11102-010-0277-9 – volume: 5 start-page: 161 year: 2010 ident: 165_CR20 publication-title: Diabetologie Stoffwechsel doi: 10.1055/s-0030-1247406 – volume: 40 start-page: 382 issue: 2 year: 2008 ident: 165_CR36 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2008.01.009 – volume: 163 start-page: 625 issue: 4 year: 2010 ident: 165_CR43 publication-title: Eur J Endocrinol doi: 10.1530/EJE-10-0246 – volume: 17 start-page: 110 issue: 3 year: 2006 ident: 165_CR3 publication-title: TEM – volume: 35 start-page: 151 issue: 3 year: 1994 ident: 165_CR29 publication-title: Biol Psychiatry doi: 10.1016/0006-3223(94)91147-9 – volume: 19 start-page: 800 issue: 4 year: 2011 ident: 165_CR34 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2010.150 – volume-title: Eur Heart J year: 2012 ident: 165_CR40 – volume: 62 start-page: 252 issue: 3 year: 2009 ident: 165_CR13 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2008.06.010 – volume: 14 start-page: 176 issue: 3 year: 2011 ident: 165_CR14 publication-title: Aging Male doi: 10.3109/13685538.2010.529194 – volume: 124 start-page: 21 issue: 1 year: 2012 ident: 165_CR4 publication-title: Postgrad Med doi: 10.3810/pgm.2012.01.2514 – volume: 97 start-page: 408 issue: 2 year: 2012 ident: 165_CR15 publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2011-2134 – volume: 34 start-page: 217 issue: 3 year: 2011 ident: 165_CR11 publication-title: Int J Androl doi: 10.1111/j.1365-2605.2010.01076.x – volume: 54 start-page: 1388 issue: 6 year: 2011 ident: 165_CR38 publication-title: Diabetologia doi: 10.1007/s00125-011-2102-z – volume: 93 start-page: 3671 issue: 10 year: 2008 ident: 165_CR5 publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2008-0222 – volume: 19 start-page: 1159 issue: 8 year: 2009 ident: 165_CR10 publication-title: Obes Surg doi: 10.1007/s11695-009-9856-0 – volume: 83 start-page: 761 issue: 3 year: 1998 ident: 165_CR42 publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.83.3.761 – volume: 89 start-page: 1328 issue: 11 year: 2010 ident: 165_CR37 publication-title: Transplantation doi: 10.1097/TP.0b013e3181d98af1 – volume: 9 start-page: 464 issue: 4 year: 2007 ident: 165_CR2 publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2006.00671.x – volume: 18 start-page: 86 issue: 1 year: 2011 ident: 165_CR17 publication-title: Eur J Cardiovasc Prev Rehabil doi: 10.1097/HJR.0b013e32833c1a8d – volume: 193 start-page: 367 issue: 3 year: 2007 ident: 165_CR35 publication-title: J Endocrinol doi: 10.1677/JOE-07-0043 – volume: 143 start-page: 1378 issue: 4 year: 2002 ident: 165_CR7 publication-title: Endocrinology doi: 10.1210/endo.143.4.8722 – volume: 31 start-page: 663 issue: 5 year: 2010 ident: 165_CR44 publication-title: Endocr Rev doi: 10.1210/er.2009-0046 – volume: 164 start-page: 751 issue: 5 year: 2011 ident: 165_CR19 publication-title: Eur J Endocrinol doi: 10.1530/EJE-10-1074 – volume: 89 start-page: 266 issue: 1 year: 2004 ident: 165_CR32 publication-title: J Clin Endocrinol Metabol doi: 10.1210/jc.2003-031295 – volume: 58 start-page: 2027 issue: 9 year: 2009 ident: 165_CR21 publication-title: Diabetes doi: 10.2337/db09-0031 – volume: 46 start-page: 85 issue: 2 year: 2009 ident: 165_CR45 publication-title: Acta Diabetol doi: 10.1007/s00592-009-0112-9 – volume: 11 start-page: 209 issue: 2 year: 2008 ident: 165_CR24 publication-title: Pituitary doi: 10.1007/s11102-008-0106-6 – reference: 11897695 - Endocrinology. 2002 Apr;143(4):1378-85 – reference: 16517173 - Trends Endocrinol Metab. 2006 Apr;17(3):110-6 – reference: 21357289 - Eur J Endocrinol. 2011 May;164(5):751-8 – reference: 18404390 - Pituitary. 2008;11(2):209-18 – reference: 9506722 - J Clin Endocrinol Metab. 1998 Mar;83(3):761-4 – reference: 19322513 - Acta Diabetol. 2009 Jun;46(2):85-95 – reference: 18834716 - J Clin Epidemiol. 2009 Mar;62(3):252-60 – reference: 18535540 - Obesity (Silver Spring). 2008 Aug;16(8):1831-7 – reference: 22843444 - Eur Heart J. 2014 May;35(18):1215-21 – reference: 19805654 - Circulation. 2009 Oct 20;120(16):1640-5 – reference: 14715860 - J Clin Endocrinol Metab. 2004 Jan;89(1):266-71 – reference: 20167617 - Int J Epidemiol. 2011 Apr;40(2):294-307 – reference: 7497617 - Clin Chem. 1995 Dec;41(12 Pt 1):1761-7 – reference: 19210705 - J Sex Med. 2009 May;6(5):1457-66 – reference: 17587388 - Diabetes Obes Metab. 2007 Jul;9(4):464-76 – reference: 22314111 - Postgrad Med. 2012 Jan;124(1):21-30 – reference: 21128120 - Pituitary. 2011 Sep;14(3):199-207 – reference: 22105468 - J Cell Physiol. 2012 Aug;227(8):3001-6 – reference: 20643758 - Eur J Endocrinol. 2010 Oct;163(4):625-30 – reference: 21394492 - Diabetologia. 2011 Jun;54(6):1388-97 – reference: 20519325 - Endocr Rev. 2010 Oct;31(5):663-79 – reference: 18664543 - J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89 – reference: 21087174 - Aging Male. 2011 Sep;14(3):176-82 – reference: 20562628 - Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):86-96 – reference: 16584506 - Clin Endocrinol (Oxf). 2006 Apr;64(4):366-70 – reference: 12630935 - Diabetes Obes Metab. 2003 Mar;5(2):106-12 – reference: 21521343 - Clin Endocrinol (Oxf). 2011 Oct;75(4):561-6 – reference: 20625974 - Exp Clin Endocrinol Diabetes. 2010 Nov;118(10):685-91 – reference: 20357700 - Transplantation. 2010 Jun 15;89(11):1328-35 – reference: 16030331 - Am J Public Health. 2005;95 Suppl 1:S144-50 – reference: 19248843 - Autoimmun Rev. 2009 Sep;9(1):23-7 – reference: 19581420 - Diabetes. 2009 Sep;58(9):2027-31 – reference: 17112339 - Annu Rev Public Health. 2007;28:95-111 – reference: 20522124 - Int J Androl. 2011 Jun;34(3):217-24 – reference: 15142985 - Endocrinology. 2004 Sep;145(9):4162-75 – reference: 22162468 - J Clin Endocrinol Metab. 2012 Feb;97(2):408-15 – reference: 12088758 - Life Sci. 2002 Jul 19;71(9):979-92 – reference: 17535875 - J Endocrinol. 2007 Jun;193(3):367-81 – reference: 20559294 - Obesity (Silver Spring). 2011 Apr;19(4):800-5 – reference: 16303834 - J Clin Endocrinol Metab. 2006 Feb;91(2):718-21 – reference: 18374075 - Transplant Proc. 2008 Mar;40(2):382-3 – reference: 19430852 - Obes Surg. 2009 Aug;19(8):1159-62 – reference: 7909693 - Biol Psychiatry. 1994 Feb 1;35(3):151-63 – reference: 22293228 - Atherosclerosis. 2012 Apr;221(2):570-6 – reference: 12562574 - Am J Psychiatry. 2003 Feb;160(2):284-9
SSID	ssj0017820
Score	2.2661912
Snippet	Background To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM),... To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), previously... Background To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM),... Doc number: 12 Abstract Background: To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2... Background: To investigate potential associations of serum prolactin concentration (PRL) with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM),...
SourceID	pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	12
SubjectTerms	Diabetes Diabetes mellitus Endocrinology Gender Insulin resistance Medicine Medicine & Public Health Metabolic Diseases Metabolic disorders Metabolic syndrome Metabolic syndrome X Physiological aspects Prolactin Research Article Risk factors rology Ships Studies Type 2 diabetes
SummonAdditionalLinks	– databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixQxEA7LKuLF96N1lQiCeohOHp1Un2QRFy8uoovuLaTTaXZgtkd2Zvz9VmW6m-1hFRRyq0qTrtQjr_qKsZezFpSTjRQQwAojayugcloYO8PgEpqoVZOLTbjjYzg9rb7sMTnkwuTX7sOVZPbU2azBvpPGKWFBaSGxode9hrEOqFrD12_fx4sDgn_rEXyu6DQJPrsu-FIM2n0fuXNJmmPP0e3_GPUddqtfaPLDrWbcZXupu8dufO6v0u-zH-glNucch7Wg3IaOR0pg7HoU3RUPK07Pzvm2IA9ftvw8rVFjFvPIB5gDjgQ6w-WKD2e47x-wk6OPJx8-ib7KgohWwVroIGcQUkPAhJXUZeNaaesGgkHXo1qZalNHyghKxpoILsaybVSokb-ZRaUfsv1u2aXHjIeqDg6XFwln30ClcPaTdDXo4Frc9oWCvR2k72OPQE6FMBY-70TAepKWJ2l5iU0V7PXY4ecWfOPPrK9oOj2ZJX4zhj67AEdGAFf-sNQG11bKVQU7mHCiOcUpeVAI35vzytOWXTuqAFywFyOZetITtS4tN5nHaHBOw994DBiggqQFe7TVsfHHlC6lsyVS3ET7RgYCAp9SuvlZBgTXhObqTMHeDDp4aehXy-vJP_A-ZTdVLgKihZIHbH99sUnP2PX4az1fXTzP9vcbmmwp_Q priority: 102 providerName: Springer Nature
Title	Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?
URI	https://link.springer.com/article/10.1186/1472-6823-13-12 https://www.ncbi.nlm.nih.gov/pubmed/23517652 https://www.proquest.com/docview/1322371527 https://www.proquest.com/docview/1324387738 https://www.proquest.com/docview/1348485612 https://pubmed.ncbi.nlm.nih.gov/PMC3614874
Volume	13
WOSCitedRecordID	wos000317358100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagRYgL70egrIyEBBxM14_EzqkqqBUculqVCpZT5DiOWGmbLc0uv58ZrxOaFfSCFEWKZhLZmfHYHtvfR8jrcW2E5hVnxpqMKV5mzORaMpWNoXOxlZOiCmQTejIxs1k-jQm3Nm6r7GJiCNTV0mGOfB9nTVIjCevBxU-GrFG4uhopNG6SXaTNRj_Xs37CxRELLsL5cJPtc6UFy4yQjMMlBj3Rdjy-0iFtb5bcWjENHdHxvf-twn1yNw5B6eHGZx6QG755SG6fxEX2R-QbxI_1OYWPL_DUQ0MdHm1sIr5uS21LcUM63VD10GVNz_0KfGkxd7QDQKAgwOwuFbTL7h48JmfHR2cfP7HIv8BcJsyKScvHxvoKIQtzLtNK1zwrK2MVBCVRc1-q0uFZIa8y5Yx2Lq0rYUvQr8ZOyCdkp1k2_hmhNi-thoGHB79QJhfgF57r0kira5gQ2oS870xRuIhNjhQZiyLMUUxWoO0KtF3B4RIJedu_cLGB5fi36hu0bYENFr7pbDx3ACVD6KviMJUKRl1C5wnZG2hCQ3NDcWfWIjb0tvhj04S86sX4Jm5ea_xyHXSUNFpLc52OMsogVWlCnm4crq-YkCnXWQoSPXDFXgEhwoeSZv4jQIVLxHnVKiHvOqe9UvS__6_n11fzBbkjAiOIZILvkZ3V5dq_JLfcr9W8vRyF9hfuZkR2PxxNpqejkOaAp-nnk-l3eDr98vU3VG08jw
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQEX3o9AASOBgIPp-pHYOaCqAqpWbVccVmJvluM4YqVttnR3Qfwo_iMz2WTprqC3HpBym0kUJ9-MPfbMNwAve5WVRpSCW28zrkWRcZsbxXXWw8nFl0HJsmk2Yfp9OxzmnzfgV1cLQ2mVnU9sHHU5CbRHvk1RkzLUhHXn9BunrlF0utq10FjA4jD-_IEh2_T9wUf8v6-k3Ps0-LDP264CPGTSzrjyomd9LImILxcqLU0lsqK0XqOpyUrEQheBKmCiznSwJoS0KqUvUL_sBeI5QI9_Bd24oVjPDJfxnSDquZY9SNhsW2gjeWal4gIvuTLxrbv_c_Pfem7m2gFtM-_t3frPvthtuNkusNnuwiLuwEas78K14zaF4B58Qe84P2E4ljHVdNQsUOFm3bIHT5mfMkq3Z4tGRGxSsZM4Q0sZjwLr6B0YCmjvmknW7V3v3IfBZYzqAWzWkzo-AubzwhtcVkVEvba5RNRHYQqrvKkw3PUJvOv-vAst8zo1ABm7JgKzmSOoOIKKE3jJBN4sbzhdkI78W_U1QcmRO8JnBt9WVeCbEbGX202VxjWlNHkCWyua6EbCqrhDkWvd2NT9gVACL5ZiupNS8-o4mTc6WlljlL1IR1ttqRFrAg8X-F4OTKpUmCxFiVlB_lKBCNBXJfXoa0OErojF1ugE3nY2cu7V__69Hl88zOdwfX9wfOSODvqHT-CGbHqfKC7FFmzOzubxKVwN32ej6dmzxvQZuEs2nN9JcZN2
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3raxQxEA9SpfilvnVr1QiC-iH28tgk-0mKeijqUbBov4VsNosH173S3fPvd2ZfdI8qiJBvM1myyTzymPkNIS9mpRWGF5xZbzVTPNfMZkYypWfgXHwRpCjaYhNmsbCnp9lxH5tTD9Huw5Nkl9OAKE1Vc3helJ2KW33IlRFMWyEZhwYW-LrCKHo8rH_7Pj4iIBRcj-ZzRaeJI9o2x5f80Xas5NaDaeuH5rf-8w9uk71-A0qPOom5Q67F6i7Z_do_sd8jP8B6bM4oDHGFOQ8VDZjYWPXoujX1NcVwdNoV6qHrkp7FBiRptQx0gD-gQMC7XSrocLf79j45mX84efeR9dUXWNDCNkx6mFIfCwQszLhMC1NynRfWKzBJouQxV3nATKGotArWhJCWhfA58BezIOQDslOtq_iIUJ_l3sC2I4JUKJsJkIrITW6lNyUcB31C3gwr4UKPTI4FMlauPaFY7XC2HM6W49BEQl6NHc47UI4_s77EpXWorvDN4PusAxgZAl-5o1Qq2HMJkyXkYMIJaham5EE4XK_mtcOjvDRYGTghz0cy9sTQtSquNy2PktYYaf_Go6yyWKg0IQ87eRt_TMiUG50CxUwkcWRAgPAppVr-bIHCJaK8GpWQ14M8Xhr61fO1_w-8z8ju8fu5-_Jp8fkxuSnaOiGSCX5AdpqLTXxCboRfzbK-eNqq5W_VbDXF
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+prolactin+concentrations+as+risk+factor+of+metabolic+syndrome+or+type+2+diabetes%3F&rft.jtitle=BMC+endocrine+disorders&rft.au=Balbach%2C+Lisa&rft.au=Wallaschofski%2C+Henri&rft.au=Volzke%2C+Henry&rft.au=Nauck%2C+Matthias&rft.date=2013-03-21&rft.issn=1472-6823&rft.eissn=1472-6823&rft.volume=13&rft.issue=1&rft.spage=12&rft.epage=12&rft_id=info:doi/10.1186%2F1472-6823-13-12&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon